1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. ARGEN X SE - ADR
Argen X SE - ADR XNAS: ARGX

Argen X SE - ADR Live Stock Price Today, Share Analysis and Chart

about

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized mya...

Read More
711.07 4.66 (0.66%)
246.4K
XNAS Volume

XNAS 03 Sep, 2025 1:28 PM (EDT)

Board Meeting
The next board meeting for Argen X SE - ADR is on 08 Sep 2025 for the purpose of argenx Morgan Stanley 23rd Annual Global Healthcare Conference 2025 See details
Medium Financial Strength
50.0 / 100
Mid Valuation
36.0 / 100
Technically Moderately Bullish
63.6 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM

Argen X SE ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..